Xermelo (telotristat ethyl) is a medication taken by mouth used to treat diarrhea in people with carcinoid syndrome who aren't responding to somatostatin analog medications alone. It's available as a brand name only, which can be expensive.
Xermelo (telotristat ethyl) is a tryptophan hydroxylase inhibitor. It blocks tryptophan hydroxylase, an enzyme (protein) that helps your body make a chemical called serotonin in your gut. People with carcinoid syndrome have too much serotonin in their gut which can cause diarrhea. Xermelo (telotristat ethyl) stops tryptophan hydroxylase from working, which lowers the amount of serotonin in the gut. This then leads to fewer bowel movements.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Contact your healthcare provider immediately if you experience any of the following.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report to your care team if they continue or are bothersome.):
No, it's only FDA approved to be used together with a somatostatin analog (SSA) (e.g., octreotide or lanreotide) for carcinoid syndrome diarrhea in people who aren't getting better with SSA alone. It's not known how well Xermelo (telotristat ethyl) works to treat diarrhea when used alone.
Yes. In fact, it's recommended that you take Xermelo (telotristat ethyl) with food. If you don't take it with food, you might not absorb all of the medication into your body, which will make it not work as well for you.
Xermelo (telotristat ethyl) can begin to work as early as 1 to 3 weeks after starting the medication. But in some people, it might take up to 3 months before you start to see a difference.
Yes, other anti-diarrheal medications can be used with Xermelo (telotristat ethyl) to help treat diarrhea. However, there might be some medications that interact with Xermelo (telotristat ethyl), so don't start any new medications without talking to your provider or pharmacist first. Make sure to tell your provider and pharmacist about all the medications you take before starting Xermelo (telotristat ethyl).
Xermelo (telotristat ethyl) hasn't been studied in people who are pregnant, so it's not completely known if it's safe or works well. Also, the studies on Xermelo (telotristat ethyl) in animals are inconsistent. If you're pregnant or thinking of getting pregnant, don't start taking Xermelo (telotristat ethyl) until you've talked to your provider first.
Xermelo (telotristat ethyl) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Since Xermelo (telotristat ethyl) lowers the number of bowel movements you have, it might cause constipation. If it becomes severe, it could lead to serious gut complications that can be life-threatening. If you develop severe constipation or severe, constant, or worsening stomach pain while taking Xermelo (telotristat ethyl), stop taking it and contact your provider right away.
The typical dose is 250 mg by mouth taken with food three times a day.
People who are currently taking and have responded well to short-acting octreotide (Sandostatin) can take Sandostatin Lar Depot (octreotide) for: